Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C173977> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- NCIT_C173977 IAO_0000115 "An Fc-modified neutralizing, recombinant, human monoclonal antibody directed against the spike (S) protein receptor binding domain (RBD) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially be used for immunization against Coronavirus disease 2019 (COVID-19). Upon administration of etesevimab, this agent specifically targets and binds to the RBD of the SARS-CoV-2 S protein. This blocks viral attachment and entry into human host cells and may thereby neutralize SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may also provide temporary protection against infection with SARS-CoV-2. S-protein, usually found on the surface of SARS-CoV-2, plays an essential role in the infection pathway of the SARS-CoV-2 virus." @default.
- NCIT_C173977 NCIT_A48 NCIT_C17998 @default.
- NCIT_C173977 NCIT_A48 NCIT_C49487 @default.
- NCIT_C173977 NCIT_A48 NCIT_C49488 @default.
- NCIT_C173977 NCIT_NHC0 "C173977" @default.
- NCIT_C173977 NCIT_P106 "Immunologic Factor" @default.
- NCIT_C173977 NCIT_P106 "Pharmacologic Substance" @default.
- NCIT_C173977 NCIT_P108 "Etesevimab" @default.
- NCIT_C173977 NCIT_P208 "CL1407894" @default.
- NCIT_C173977 NCIT_P210 "2423948-94-9" @default.
- NCIT_C173977 NCIT_P319 "N7Q9NLF11I" @default.
- NCIT_C173977 NCIT_P322 "ACC/AHA" @default.
- NCIT_C173977 NCIT_P322 "FDA" @default.
- NCIT_C173977 NCIT_R124 NCIT_C17710 @default.
- NCIT_C173977 NCIT_R124 NCIT_C17828 @default.
- NCIT_C173977 NCIT_R124 NCIT_C18219 @default.
- NCIT_C173977 NCIT_R124 NCIT_C19986 @default.
- NCIT_C173977 NCIT_R124 NCIT_C40474 @default.
- NCIT_C173977 normalizedInformationContent "100" @default.
- NCIT_C173977 referenceCount "1" @default.
- NCIT_C173977 hasExactSynonym "Anti-COVID-19 Monoclonal Antibody JS016" @default.
- NCIT_C173977 hasExactSynonym "Anti-COVID-19 Spike Protein Monoclonal Antibody JS016" @default.
- NCIT_C173977 hasExactSynonym "Anti-SARS-CoV-2 Monoclonal Antibody JS016" @default.
- NCIT_C173977 hasExactSynonym "ETESEVIMAB" @default.
- NCIT_C173977 hasExactSynonym "Etesevimab" @default.
- NCIT_C173977 hasExactSynonym "JS 016" @default.
- NCIT_C173977 hasExactSynonym "JS-016" @default.
- NCIT_C173977 hasExactSynonym "JS016" @default.
- NCIT_C173977 hasExactSynonym "Monoclonal antibodies against SARS-CoV-2: etesevimab" @default.
- NCIT_C173977 inSubset NCIT_C173381 @default.
- NCIT_C173977 inSubset NCIT_C173383 @default.
- NCIT_C173977 inSubset NCIT_C191200 @default.
- NCIT_C173977 inSubset NCIT_C191387 @default.
- NCIT_C173977 inSubset NCIT_C191404 @default.
- NCIT_C173977 inSubset NCIT_C191670 @default.
- NCIT_C173977 inSubset NCIT_C63923 @default.
- NCIT_C173977 type Class @default.
- NCIT_C173977 isDefinedBy ncit.owl @default.
- NCIT_C173977 label "Etesevimab" @default.
- NCIT_C173977 subClassOf NCIT_C173741 @default.
- NCIT_C173977 subClassOf NCIT_C173977 @default.
- NCIT_C173977 subClassOf NCIT_C1908 @default.
- NCIT_C173977 subClassOf NCIT_C1909 @default.
- NCIT_C173977 subClassOf NCIT_C20401 @default.
- NCIT_C173977 subClassOf NCIT_C307 @default.
- NCIT_C173977 subClassOf NCIT_C308 @default.